ORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Orexo is a Swedish pharmaceutical company that develops improved medicines based on proprietary formulation technologies and with a focus on meeting major medical needs. In the US market, Orexo commercializes treatments for patients suffering from opioid addiction. Products targeting other therapeutic areas are developed and commercialized worldwide through partners.
Læs mereOmsætning mio.
EBIT-% (adj.)
EPS (adj.)
Udbytte %
Ekstraordinær generalforsamling '26
Årsrapport '26
Delårsrapport Q1'27
Gå ikke glip af noget - opret en konto og få alle de mulige fordele